Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
2013
Treatment of kidney cancer
2009 StandoutNobel
Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumours
1999
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting
2003
EGFR Antagonists in Cancer Treatment
2008 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Hepatocellular carcinoma
2003 Standout
Hepatocellular carcinoma
2018 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Central venous catheter practices: Results of a survey
1995
Comparing antibody and small-molecule therapies for cancer
2006
Ovarian cancer
2014 Standout
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
2009
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer
2001
Antithrombotic Therapy for VTE Disease
2016 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Hepatocellular carcinoma
2012 Standout
Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment
1995
Hepatocellular carcinoma
2021 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Acute Pancreatitis
2016 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience
1997
Pancreatitis-Diabetes-Pancreatic Cancer
2013
Chronic hepatitis B
2007 Standout
Treatment of small hepatocellular carcinomas
1992
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
2016
Transarterial therapies for hepatocellular carcinoma
2011
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
1998
The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033
2002
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
2006
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
1998
Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
2006
Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
1997
Microtubules as a target for anticancer drugs
2004 Standout
Emerging drugs for non-small-cell lung cancer
2007
Small-cell lung cancer
2005
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Staging of non-small cell lung cancer: consensus, controversies and challenges
2001
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin
2015
Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs
2002
Cyclophosphamide and Etoposide for Non-Small Cell and Small Cell Lung Cancer
1999
Hepatocellular carcinoma
2022 Standout
The dawning era of polymer therapeutics
2003 Standout
Cancer of the Ovary
2004 Standout
Gender differences in drug responses
2006
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors
1983
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer
2000
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
2001
Sampling the Antibiotic Resistome
2006 StandoutScience
Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study
2000
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
2003 Standout
A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC).
1995 StandoutNobel
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Cost-Effectiveness of Adding Granulocyte Colony-Stimulating Factor to Primary Prophylaxis With Antibiotics in Small-Cell Lung Cancer
2006
Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer
2007
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
Metabolism of oxazaphosphorines
1988
Intraperitoneal treatment and dose-intense therapy in ovarian cancer
1999
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Targeted therapy for advanced renal cell carcinoma
2008
Works of P. Harper being referenced
Is repeated flushing of Hickman catheters necessary?
1985
Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy
1997
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial
1991
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer
1989
A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma
1993
Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry
1995
Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol
1991
Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests
1992
Assessment of ’quality of life’ using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer
1995
Pancreatic cancer treatment and research: an international expert panel discussion
2011
Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group.
1998
5‐FLUOROURACIL‐INDUCED ERYTHEMA MULTIFORME
1999
1 Phase II trial of navelbine (NVB), in small cell lung cancer (SCLC)
1997
Neuroepithelioma—a rare malignant peripheral nerve tumor of primitive origin: Report of two new cases and a review of the literature
1981
Decreased plasma half-life of cyclophosphamide during repeated high-dose administration
1983
Pretreatment minimal staging for non-small cell lung cancers: a consensus report
1991
Efficacy of lapatinib in patients with high tumor EGFR expression: Results of a phase III trial in advanced renal cell carcinoma (RCC)
2006
T cell regeneration after allogeneic and autologous bone marrow transplantation
1983